Dextrose Fresenius 10 % 100 g Solution for infusion.

    Dextrose Fresenius 10 % 100 g Solution for infusion.

    S3
    PDF Leaflet Revision Date: 08 March 2022


    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Source of calories and hydration.

    Dosage (summary)

    Dosage directed by a doctor; monitor glucose and electrolytes.

    Special Populations

    • Elderly
    • Paediatric population

    Pregnancy & Breastfeeding

    Use with caution during pregnancy; safety in lactation not established.

    Key Drug Interactions

    • Catecholamines
    • Steroids
    • Diuretics

    Contraindications

    • Hypersensitivity to dextrose
    • Uncompensated diabetes
    • Severe renal insufficiency

    Common side effects

    • Hyperglycaemia
    • Fluid and electrolyte disturbances
    • Vein irritation

    Counselling Points

    • Monitor blood glucose regularly
    • Avoid rapid infusion
    • Report any allergic reactions

    Serious warnings

    • Risk of hyperglycaemia
    • Refeeding syndrome
    • Hypersensitivity reactions
    Important Disclaimer

    The Dextrose Fresenius 10 % 100 g Solution for infusion. professional information leaflet below is the property of Fresenius Kabi Manufacturing Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn